Quite a few analysts have predicted that the stocks of CVX would be announcing a sales sum of $31.22 billion for the present quarter. Three of the investment analysts working for the firm have already provided estimates into the earnings of the company- with the ball rolling at $27.51 billion and coming to an end at $34.10 billion.
The company did put up a sales sum of $31.50 billion the previous year- so this is indicative of a negative annual growth rate of about 0.9%. The company will be putting up their next report quarterly earnings on the 7th of May.
The Stock Commentary of CVX
The stocks of CVX have been subjected to quite a few research reports. Scotiabank has already put up a rating of sector perform, along with a price rating of $115 in a 16th March research report. Wells Fargo & Company have also gone ahead and dropped the price target of the company from $105 to $99, with a rating of equal weight in a 1st February research report.
Mizuho Securities has already given the company a rating of buy with a price target of $107. Truist has also gone down the same road with a price target increased to $130. In the end, Evercore ISI gave a rating of outperform to the company with a price target set at $130.
Ten of the investment equities involved with the firm provided it with a rating of hold, while nineteen of them gave it a rating of buy. Currently, CVX has a buy rating with a $109.39 consensus price target.
The stocks of CVX traded on Thursday at $104.70. The year low of the firm has been $65.16, with a year high set at $112.70. The moving average price of the company over 50 days is $100.12, while the moving average price of the company over 200 days is $86.68. The current ratio of the company is 1.26, while they also enjoy a 0.26 debt-to-equity ratio.
